# Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)

> **NCT02216773** · NA · COMPLETED · sponsor: **Imperial College London** · enrollment: 57 (actual)

## Conditions studied

- Liver Resection
- Cancer

## Interventions

- **PROCEDURE:** Radiofrequency assisted liver partition with portal vein ligation (RALPP)
- **PROCEDURE:** Portal vein embolization (PVE)

## Key facts

- **NCT ID:** NCT02216773
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2019-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216773, "Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02216773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*